Calcium antagonist agents in hypertrophic cardiomyopathy

This publication has 21 references indexed in Scilit:

• Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy.
  Circulation, 1985
• Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.
  Circulation, 1985
• Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.
  Heart, 1984
• Hypertrophic cardiomyopathy—Therapy with slow channel inhibiting agents
  Progress in Cardiovascular Diseases, 1982
• Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy.
  Circulation, 1982
• Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration
  The American Journal of Cardiology, 1981
• Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.
  Circulation, 1979
• Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.
  Circulation, 1979
• Treatment of hypertrophic obstructive cardiomyopathy with verapamil.
  Heart, 1979
• Calciumantagonistische Therapie bei hypertroph-obstruktiver Kardiomyopathie
  Deutsche Medizinische Wochenschrift (1946), 1976